Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5572373 | 1.00 | TP53 (0.47) | TP53ACE2FDPSCA2MAPK1 | |
| SCHEMBL8812277 | 0.93 | TP53 (0.55) | TP53ACE2FDPSCA1MAPT | |
| SCHEMBL11503915 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL29194302 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL5460470 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL17832974 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL11573155 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL8908063 | 0.91 | TP53 (0.53) | TP53ACE2FDPSCA2CA1 | |
| SCHEMBL1773515 | 0.86 | TSHR (0.46) | TP53FDPSCA2CA1SLC22A6 | |
| SCHEMBL21853613 | 0.82 | APP (0.41) | TP53SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | ME1, ME3, ACMSD | TP53 4342/4885ACE2 1773/4885FDPS 1056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.